Safe and efficient practice of parenteral nutrition in neonates and children aged 0-18 years - The role of licensed multi-chamber bags.

Multi-chamber bag Parenteral nutrition Patient safety Pediatrics Preterm infants Standardization

Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
15 May 2024
Historique:
received: 15 01 2023
revised: 11 04 2024
accepted: 12 05 2024
medline: 2 6 2024
pubmed: 2 6 2024
entrez: 1 6 2024
Statut: aheadofprint

Résumé

Parenteral nutrition (PN) is recognized as a complex high-risk therapy. Its practice is highly variable and frequently suboptimal in pediatric patients. Optimizing care requires evidence, consensus-based guidelines, audits of practice, and standardized strategies. Several pediatric scientific organizations, expert panels, and authorities have recently recommended that standardized PN should generally be used over individualized PN in the majority of pediatric patients including very low birth weight premature infants. In addition, PN admixtures produced and validated by a suitably qualified institution are recommended over locally produced PN. Licensed multi chamber bags are standardized PN bags that comply with Good Manufacturing Practice and high-quality standards for the finished product in the frame of their full manufacturing license. The purpose of this article is to review the practical aspects of PN and the evidence for using such multi-chamber bags in pediatric patients. It highlights the safety characteristics and the limitations of the different PN practices and provides some guidance for ensuring safe and efficient therapy in pediatric patients.

Identifiants

pubmed: 38823267
pii: S0261-5614(24)00169-9
doi: 10.1016/j.clnu.2024.05.023
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1696-1705

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest VC, MD, NH, JR, MSDP, ST, FV, DW, and CvdA have received honoraria from Baxter Healthcare Corporation for symposium participation or scientific education activity. HA has received honoraria from Baxter Healthcare Corporation and Fresenius Kabi for symposium participation or scientific education activity. MP has received honoraria from Baxter Healthcare Corporation, Fresenius Kabi, and B. Braun for symposium participation or education scientific activity. MD, VC and MT have received investigator-initiated research grants from the Baxter Healthcare Corporation (money paid to their institutions). TS is an employee of Baxter Healthcare Corporation. PL and LO have no conflicts of interest to declare.

Auteurs

Thibault Senterre (T)

Baxter R&D Europe, Braine-l'Alleud, Belgium; University of Liège, Liège, Belgium. Electronic address: Thibault_Senterre@baxter.com.

Chris H P van den Akker (CHP)

Department of Pediatrics - Neonatology, Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Amsterdam, the Netherlands; Amsterdam Reproduction and Development and Amsterdam Gastroenterology Endocrinology Metabolism Research Institutes, Amsterdam, the Netherlands. Electronic address: c.h.vandenakker@amsterdamumc.nl.

Magnus Domellof (M)

Department of Clinical Sciences, Umeå University, Umea, Sweden. Electronic address: magnus.domellof@umu.se.

Miguel Saenz de Pipaon (M)

Instituto de Investigación Sanitaria del Hospital Universitario La Paz - IdiPAZ, (Hospital Universitario La Paz - Universidad Autónoma de Madrid), Madrid, Spain. Electronic address: miguel.saenz@salud.madrid.org.

Henrik Arnell (H)

Department of Pediatric Gastroenterology, Hepatology and Nutrition, Astrid Lindgren Children's Karolinska University Hospital, Stockholm, Sweden; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. Electronic address: henrik.arnell@karolinska.se.

Merit Tabbers (M)

Amsterdam Reproduction and Development and Amsterdam Gastroenterology Endocrinology Metabolism Research Institutes, Amsterdam, the Netherlands; Department of Pediatric Gastroenterology, Hepatology and Nutrition, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: m.m.tabbers@amsterdamumc.nl.

Frederic V Valla (FV)

Transversal dietetics and Nutrition Unit and Nutrition Unit (UTDN), Intensive Care Nutrition, Hospices Civils de Lyon, Lyon-Bron, France. Electronic address: frederic.valla@chu-lyon.fr.

Stephen Tomlin (S)

Pharmacy Department, Children's Medicines Centre, Great Ormond Street Hospital for Sick Children, London, UK. Electronic address: Stephen.Tomlin@gosh.nhs.uk.

Mattias Paulsson (M)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden. Electronic address: Mattias.paulsson@kbh.uu.se.

Dirk Wackernagel (D)

Department of Neonatology, Gutenberg University, Mainz, Germany; CLINTEC, Karolinska Institutet, Stockholm, Sweden. Electronic address: dirk.wackernagel@unimedizin-mainz.de.

Nadja Haiden (N)

Department of Neonatology, Kepler University Hospital, Linz, Austria. Electronic address: nadja@haiden.eu.

Päivi Luukkainen (P)

Children's Hospital, University of Helsinki, Helsinki, Finland. Electronic address: Paivi.Luukkainen@hus.fi.

Luigi Orfeo (L)

Neonatal Intensive Care Unit, Isola Tiberina Hospital Gemelli Isola, Rome, Italy. Electronic address: orfeo@iol.it.

Virgilio P Carnielli (VP)

Department of Mother and Child Health, Division of Neonatology, G. Salesi Children's Hospital - Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Italy; Department of Odontostomatologic and Specialized Clinical Sciences, Polytechnic University of Marche, Ancona, Italy. Electronic address: v.carnielli@staff.univpm.it.

Jacques Rigo (J)

University of Liège, Liège, Belgium. Electronic address: rigojacques@gmail.com.

Classifications MeSH